Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration

MLA

Kiriyama, A., et al. “Plasma Pharmacokinetics and Urinary and Biliary Excretion of a New Potent Tripeptide HIV-1 Protease Inhibitor, KNI-272, in Rats after Intravenous Administration.” AIDS Weekly, 21 Nov. 1994, p. 29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.15904370&authtype=sso&custid=ns315887.

APA

Kiriyama, A., Fujita, K., Takemura, S., Kuramoto, H., Kiso, Y., & Takada, K. (1994, November 21). Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration. AIDS Weekly, 29.

Chicago

Kiriyama, A., K. Fujita, S. Takemura, H. Kuramoto, Y. Kiso, and K. Takada. 1994. “Plasma Pharmacokinetics and Urinary and Biliary Excretion of a New Potent Tripeptide HIV-1 Protease Inhibitor, KNI-272, in Rats after Intravenous Administration.” AIDS Weekly, November 21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.15904370&authtype=sso&custid=ns315887.